NCCS presents third annual Ellen Stovall Award to Gay Crawford and Norman Coleman

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

The National Coalition for Cancer Survivorship presented the third annual Ellen L. Stovall Award for Innovation in Patient-Centered Cancer Care to Gay Crawford, founding director of Cancer CAREpoint, and Norman Coleman, senior investigator at NCI.

Since her diagnosis of breast cancer at age 30, Crawford spent the last 44 years playing a leadership role in bringing patient-focused cancer care to the Silicon Valley area. She helped found and lead numerous organizations, including the non-profit organization Cancer CAREPoint, which provides a wide-range of cancer support services in Silicon Valley free of charge.

Coleman is the director of the Radiation Oncology Sciences Program. Coleman leads a laboratory at NCI focusing on radiation-induced molecular and immunotherapy targets.

Named for former NCCS CEO, Ellen Stovall, who died in 2016 due to complications from three cancer treatments, the award seeks to highlight those who continue Ellen’s work of transforming cancer care to further incorporate patients’ goals, needs, and values.

More information about Crawford, Coleman, and the Ellen Stovall Award can be found here.

Table of Contents

YOU MAY BE INTERESTED IN

Physician-scientists by day, a funk-loving musical troupe by night. You may have seen The CheckPoints—a 13 member cover band with a three-piece brass section and Jim Allison on harmonica—movin’, groovin’, and gettin’ down as a mainstay closing act at ASCO, AACR, or the Society for Immunotherapy of Cancer annual meetings. 
At the 2026 Annual Meeting of the American Society of Clinical Oncology in Chicago, results from the phase III HARMONi-6 trial were presented at the plenary session and published simultaneously in The Lancet. The HARMONi-6 trial tested a novel bispecific antibody that engages PD-1 and VEGF (ivonescimab), given with platinum-doublet chemotherapy to patients with previously untreated advanced squamous non-small cell lung cancer. 
In 2026, more than 900 million people are estimated to be regularly using generative artificial intelligence—computer systems capable of creating human-like text, images, audio, video, and other original content. AI is becoming integrated into nearly every aspect of daily life. Health care is no exception. 

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login